American Journal of Biomedical Research
ISSN (Print): 2328-3947 ISSN (Online): 2328-3955 Website: https://www.sciepub.com/journal/ajbr Editor-in-chief: Hari K. Koul
Open Access
Journal Browser
Go
American Journal of Biomedical Research. 2021, 9(2), 36-42
DOI: 10.12691/ajbr-9-2-3
Open AccessArticle

Relationship between COVID-19 Infection and ABO Blood Groups Differences: A Tertiary Centre Experience in Al-Madinah, Saudi Arabia

Abdulhalem A. Jan1, Ahmed M. Aljeraisi2, Abdullah M. Algarni3, Mohammed A. Almozini4, Nashwa A. Alsyed5, Suliman A. Alharbi6, Muhammad A. Tobaiqi7, Hemaed Aljabri8, Nasser M. Mulla1, 7, Alaa A. Alsayed9 and Salah Mohamed El Sayed10, 11,

1Laboratory and Blood Bank Director, King Fahad Hospital, Al-Madinah, Saudi Arabia

2Rehabilitation Hospital, Al-Madinah, Saudi Arabia

3Infection Control, King Fahad Hospital, Al-Madinah, Saudi Arabia

4Laboratory, King Fahad Hospital, Al-Madinah, Saudi Arabia

5Quality control, King Fahad Hospital, Al-Madinah, Saudi Arabia

6Immunology department, King Fahad Hospital, Al-Madinah, Saudi Arabia

7Department of Medicine, Taibah University, Al-Madinah, Saudi Arabia

8Blood Bank Department, King Fahad Hospital, Madinah

9Chief Risk Officer, Madinah Health Cluster, Al-Madinah, Saudi Arabia

100Department of Clinical Biochemistry and Molecular Medicine, Taibah Faculty of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia

111Department of Medical Biochemistry, Sohag Faculty of Medicine, Sohag University, Egypt

Pub. Date: November 04, 2021

Cite this paper:
Abdulhalem A. Jan, Ahmed M. Aljeraisi, Abdullah M. Algarni, Mohammed A. Almozini, Nashwa A. Alsyed, Suliman A. Alharbi, Muhammad A. Tobaiqi, Hemaed Aljabri, Nasser M. Mulla, Alaa A. Alsayed and Salah Mohamed El Sayed. Relationship between COVID-19 Infection and ABO Blood Groups Differences: A Tertiary Centre Experience in Al-Madinah, Saudi Arabia. American Journal of Biomedical Research. 2021; 9(2):36-42. doi: 10.12691/ajbr-9-2-3

Abstract

Controversial factors affecting COVID-19 infection include age, ethnicity, blood groups and Rh factor were investigated here. This study enrolled 2012 participants: COVID-19 cases (1006 patients), and control group (1006 subjects), 50.9% were Saudis and 49.1% were non-Saudis. Mean age for all participants was 36.0±12.7 years and ranged from 8 to 80 years. Mean age was 38.6+15.3 years for COVID-19+ve cases and 33.4±8.6 years for controls. Mean age significantly differed in COVID-19+ve cases from controls (p<0.001). COVID-19 infection was significant in Saudi participants compared to non-Saudi participants (p<0.001). In COVID-19 group, the frequencies of blood groups O, A, B and AB were 44.5%, 31.3%, 19.7% and 4.5%, respectively. The percentage of COVID-19 infection was higher in subjects having blood groups O and A. Regarding Rh factor, 94.0% of all participants were Rh+ve and 6.0% were Rh-ve. Among COVID+ve cases, 93.4% were Rh positive cases and 6.6% were Rh negative cases, while in the controls, 94.5% were Rh+ve and 5.5% were Rh-ve. The number of COVID-19+ve cases exceeded the number of healthy controls in A+ve subjects but not in O+ve and B+ve subjects. In multivariate analysis, people with blood groups B and AB were less likely to be infected (p =0.049) compared to those with groups O and A. In conclusion, older adults had greater risk of COVID-19 infection. Gatherings culture increased COVID-19 infection. Individuals with blood groups B and AB are less likely to get COVID-19 infection than O and A subjects. Rh+ve in O+ve and A+ve is associated with increased COVID-19 infection.

Keywords:
COVID-19 Rh+ve Rh-ve ABO blood groups ethnicity COVID-19 infection

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  Wu Y, Feng Z, Li P, Yu Q. Relationship between ABO blood group distribution and clinical characteristics in patients with COVID-19. Clin Chim Acta. 2020; 509: 220-223.
 
[2]  El Sayed SM, Almaramhy HH, Aljehani YT, Okashah AM, El-Anzi ME, AlHarbi MB, et al. The evidence-based TaibUVID nutritional treatment for minimizing covid-19 fatalities and morbidity and eradicating COVID-19 pandemic: a novel approach for better outcomes (A Treatment Protocol) Am J Public Health Res. 2020; 8: 54-60.
 
[3]  El Sayed SM, Bahashwan SA, Aboonq MS, Hussam Baghdadi H, Elshazley M, Okashah AM, et al. IJMDC. 2020; 4: 1375-1389.
 
[4]  El Sayed SM, Aboonq MS, El Rashedy AG, Aljehani YT, Abou El-Magd RM, Okashah AM, et al. Promising preventive and therapeutic effects of TaibUVID nutritional supplements for COVID-19 pandemic: towards better public prophylaxis and treatment (A retrospective study). Am J Blood Res. 2020; 10: 266-282.
 
[5]  El Sayed SM, Aboonq MS, Aljehani YT, Hassan MA, Abou El-Magd RM, Abdelrahman AI, et al. TaibUVID nutritional supplements help rapid cure of COVID-19 infection and rapid reversion to negative nasopharyngeal swab PCR: for better public prophylaxis and treatment of COVID-19 pandemic. Am J Blood Res. 2020; 10: 397-406.
 
[6]  Barnkob MB, Pottegård A, Støvring H, Haunstrup TM, Homburg K, Larsen R, et al. Reduced prevalence of SARS-CoV-2 infection in ABO blood group O. Blood Adv. 2020; 4: 4990-4993.
 
[7]  Gérard C, Maggipinto G, Minon JM. COVID-19 and ABO blood group: another viewpoint. Br J Haematol. 2020; 190: e93-e94.
 
[8]  Muñiz-Diaz E, Llopis J, Parra R, Roig I, Ferrer G, Grifols J, et al. Relationship between the ABO blood group and COVID-19 susceptibility, severity and mortality in two cohorts of patients. Blood Transfus. 2021; 19: 54-63.
 
[9]  Amoroso A, Magistroni P, Vespasiano F, Bella A, Bellino S, Puoti F, et al. Italian Network of Regional Transplant Coordinating Centers. HLA and AB0 Polymorphisms May Influence SARS-CoV-2 Infection and COVID-19 Severity. Transplantation. 2021; 105: 193-200.
 
[10]  Boudin L, Janvier F, Bylicki O, Dutasta F. ABO blood groups are not associated with risk of acquiring the SARS-CoV-2 infection in young adults. Haematologica. 2020; 105: 2841-2843.
 
[11]  Göker H, Aladağ Karakulak E, Demiroğlu H, Ayaz Ceylan ÇM, Büyükaşik Y, Inkaya AÇ, et al. The effects of blood group types on the risk of COVID-19 infection and its clinical outcome. Turk J Med Sci. 2020; 50: 679-683.
 
[12]  Golinelli D, Boetto E, Maietti E, Fantini MP. The association between ABO blood group and SARS-CoV-2 infection: A meta-analysis. PLoS One. 2020; 15: e0239508.
 
[13]  Niles JK, Karnes HE, Dlott JS, Kaufman HW. Association of ABO/Rh with SARS-CoV-2 positivity: The role of race and ethnicity in a female cohort. Am J Hematol. 2021; 96: E23-E26.
 
[14]  Fan Q, Zhang W, Li B, Li DJ, Zhang J, Zhao F. Association Between ABO Blood Group System and COVID-19 Susceptibility in Wuhan. Front Cell Infect Microbiol. 2020; 10: 404.
 
[15]  Flegel WA. COVID-19: risk of infection is high, independently of ABO blood group. Haematologica. 2020; 105: 2706-2708.
 
[16]  Latz CA, DeCarlo C, Boitano L, Png CYM, Patell R, Conrad MF, et al. Blood type and outcomes in patients with COVID-19. Ann Hematol. 2020; 99: 2113-2118.